PR Newswire - Robust Sales of Integrilin, ReoPro and Aggrastat Will Drive the Unstable Angina/Non-ST-Elevation Myocardial Infarction Drug Market
September 9, 2008 -- Premium Priced Drug Classes Account for 70 Percent of Market Sales, According to a New Report from Decision Resources WALTHAM, Mass., Sept. 9...
PR Newswire Europe - Patient Enrollment Permanently Discontinued in Investigational Clinical Trial of REOPRO(R) (abciximab) for Acute Ischemic Stroke.
October 28, 2005 -- HORSHAM, Pennsylvania and INDIANAPOLIS, October 28 /PRNewswire/ -- Centocor, Inc. and Eli Lilly and Company announced today that patient...
PR Newswire Europe - Patient Enrollment Temporarily Suspended in Investigational Clinical Trial of REOPRO(R) (abciximab) for Acute Ischemic Stroke.
October 4, 2005 -- HORSHAM, Pennsylvania and INDIANAPOLIS, October 4 /PRNewswire/ -- Centocor, Inc. and Eli Lilly and Company announced today that enrollment in...
Market Wire - Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session
April 3, 2008 -- Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular-focused biopharmaceutical company, today commented on the positive results of two large...
Canadian Corporate News - Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session.
April 3, 2008 -- WINNIPEG, MANITOBA, Apr 3, 2008 (Marketwire via COMTEX) -- Medicure Inc. (TSX:MPH)(AMEX:MCU), a cardiovascular-focused biopharmaceutical company,...
Business Wire - New AbESTT Data Show Significant Benefits of Reopro-R- in Ischaemic Stroke
May 23, 2003 -- Business Editors VALENCIA, Spain--(BUSINESS WIRE)--May 23, 2003 Two New Presentations at the European Stroke Conference in Valencia Show That...
Pharma Marketletter - Clinical trial finds ReoPro may cut disability, death in ischemic stroke.
February 24, 2003 -- Individuals who suffer an ischemic stroke may soon have a new treatment option, now that a clinical trial has suggested that Eli Lilly/Centocor's...
Heart Advisor - The risks and benefits of glycoprotein IIb/IIIa inhibitors; these drugs are used to treat possible heart attacks and to prevent clotting during angioplasty,...
October 1, 2007 -- Glycoprotein IIb/IIIa (GPIIb/ IIIa) inhibitors are powerful medications that prevent platelets from sticking together and forming a clot. Different...
Internal Medicine News - Dual-protection scheme boosts renal stenting outcomes in RESIST trial
May 15, 2007 -- NEW ORLEANS -- The key to preserving kidney function following renal artery stenting appears to be utilizing the dual protection provided by an...
Market Wire - Medicure Announces New AGGRASTAT'R' Data at 2006 Scientific Sessions of the American Heart Association
November 14, 2006 -- Medicure Inc. (TSX: MPH)(AMEX: MCU), a cardiovascular focused biopharmaceutical company, today announced that new data comparing Single High-Dose...
